Evidence map›Paper›PMID 34641479›Full record

ArticleMolecules (Basel, Switzerland)2021

A Uniform Benchmark for Testing SsrA-Derived Degrons in the

Maria Magdalena Klimecka, Anna Antosiewicz, Matylda Anna Izert, Patrycja Emanuela Szybowska, Piotr Krzysztof Twardowski, Clara Delaunay, Maria Wiktoria Górna

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Evaluation of Degron Motifs in Escherichia coli Using a Fluorescent Reporter.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. GoldenBraid2.0Synthetic biology (Oxford, England) · 2025
    Article
  9. Review
  10. Proteolytic stability and aggregation in a key metabolic enzyme of bacteria.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Maria Magdalena KlimeckaStructural Biology Group, Biological and Chemical Research Centre, Department of Chemistry, University of Warsaw, 00-927 Warsaw, Poland.
Anna AntosiewiczStructural Biology Group, Biological and Chemical Research Centre, Department of Chemistry, University of Warsaw, 00-927 Warsaw, Poland.ORCID 0000-0002-0136-6077
Matylda Anna IzertStructural Biology Group, Biological and Chemical Research Centre, Department of Chemistry, University of Warsaw, 00-927 Warsaw, Poland.ORCID 0000-0003-1782-8229
Patrycja Emanuela SzybowskaStructural Biology Group, Biological and Chemical Research Centre, Department of Chemistry, University of Warsaw, 00-927 Warsaw, Poland.
Piotr Krzysztof TwardowskiStructural Biology Group, Biological and Chemical Research Centre, Department of Chemistry, University of Warsaw, 00-927 Warsaw, Poland.
Clara DelaunayStructural Biology Group, Biological and Chemical Research Centre, Department of Chemistry, University of Warsaw, 00-927 Warsaw, Poland.
Maria Wiktoria GórnaStructural Biology Group, Biological and Chemical Research Centre, Department of Chemistry, University of Warsaw, 00-927 Warsaw, Poland.
University of Warsaw · PL

Funding

European Molecular Biology Organization Installation Grant 3315Foundation for Polish Science POIR.04.04.00-00-5EC1/18-00
6 · The paper itself

Abstract

The ssrA degron is commonly used in fusion proteins to control protein stability in bacteria or as an interaction module. These applications often rely on the modular activities of the ssrA tag in binding to the SspB adaptor and in engaging the ClpXP protease. However, a comparison of these activities for a substantial standard set of degron variants has not been conducted previously, which may hinder the development of new variants optimized exclusively for one application. Here, we strive to establish a benchmark that will facilitate the comparison of ssrA variants under uniform conditions. In our workflow, we included methods for expression and purification of ClpX, ClpP, SspB and eGFP-degrons, assays of ClpX ATPase activity, of eGFP-degron binding to SspB and for measuring eGFP-degron degradation in vitro and in vivo. Using uniform, precise and sensitive methods under the same conditions on a range of eGFP-degrons allowed us to determine subtle differences in their properties that can affect their potential applications. Our findings can serve as a reference and a resource for developing targeted protein degradation approaches.

Indexed as

Adenosine TriphosphateCarrier ProteinsEndopeptidase ClpEscherichia coliEscherichia coli ProteinsGreen Fluorescent ProteinsModels, MolecularProtein BindingSubstrate SpecificityAdenosine TriphosphateCarrier ProteinsClpXP protease, E coliEndopeptidase ClpEscherichia coli ProteinsGreen Fluorescent ProteinssspB protein, E coliClpXPdegradationdegronproteaseSspBssrA

Identifiers

PMID34641479
PMCPMC8512704
OpenAlexW3202622521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.